Savi et al., 2016 - Google Patents
Antiarrhythmic effect of growth factor-supplemented cardiac progenitor cells in chronic infarcted heartSavi et al., 2016
View PDF- Document ID
- 12630973752915425391
- Author
- Savi M
- Bocchi L
- Rossi S
- Frati C
- Graiani G
- Lagrasta C
- Miragoli M
- Di Pasquale E
- Stirparo G
- Mastrototaro G
- Urbanek K
- De Angelis A
- Macchi E
- Stilli D
- Quaini F
- Musso E
- Publication year
- Publication venue
- American Journal of Physiology-Heart and Circulatory Physiology
External Links
Snippet
c-Kitpos cardiac progenitor cells (CPCs) represent a successful approach in healing the infarcted heart and rescuing its mechanical function, but electrophysiological consequences are uncertain. CPC mobilization promoted by hepatocyte growth factor (HGF) and IGF-1 …
- 230000000747 cardiac effect 0 title abstract description 111
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Savi et al. | Antiarrhythmic effect of growth factor-supplemented cardiac progenitor cells in chronic infarcted heart | |
| US20210260158A1 (en) | Transcription factor-based generation of pacemaker cells and methods of using same | |
| Egom et al. | Impaired sinoatrial node function and increased susceptibility to atrial fibrillation in mice lacking natriuretic peptide receptor C | |
| Otake et al. | Influences of autonomic nervous system on atrial arrhythmogenic substrates and the incidence of atrial fibrillation in diabetic heart | |
| Takagawa et al. | Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area-and length-based approaches | |
| Bocchi et al. | Growth factor-induced mobilization of cardiac progenitor cells reduces the risk of arrhythmias, in a rat model of chronic myocardial infarction | |
| Carnevali et al. | Signs of cardiac autonomic imbalance and proarrhythmic remodeling in FTO deficient mice | |
| Miragoli et al. | Atrial fibrillation and fibrosis: beyond the cardiomyocyte centric view | |
| US20100189701A1 (en) | Methods and compositions to treat arrhythmias | |
| Kelemen et al. | Heterogeneous repolarization creates ventricular tachycardia circuits in healed myocardial infarction scar | |
| Wang et al. | Inhibition of angiotensin II-induced cardiac hypertrophy and associated ventricular arrhythmias by a p21 activated kinase 1 bioactive peptide | |
| Fo et al. | Chronic sigma-1 receptor activation ameliorates ventricular remodeling and decreases susceptibility to ventricular arrhythmias after myocardial infarction in rats | |
| Fernandes et al. | Cardiac cell therapy: overexpression of connexin43 in skeletal myoblasts and prevention of ventricular arrhythmias | |
| Sharma et al. | New drug discovery of cardiac anti-arrhythmic drugs: Insights in animal models | |
| Igarashi et al. | Linagliptin prevents atrial electrical and structural remodeling in a canine model of atrial fibrillation | |
| Sorrentino et al. | Myocyte repolarization modulates myocardial function in aging dogs | |
| Kang et al. | Effect of ATP-sensitive potassium channel agonists on sympathetic hyperinnervation in postinfarcted rat hearts | |
| Coronel et al. | Cardiac expression of skeletal muscle sodium channels increases longitudinal conduction velocity in the canine 1-week myocardial infarction | |
| Aguilar et al. | Mammalian enabled (Mena) is a critical regulator of cardiac function | |
| Landi et al. | Lack of the transcription factor Nfix causes tachycardia in mice sinus node and rats neonatal cardiomyocytes | |
| Gajzer et al. | Thymosin β4 and cardiac regeneration: are we missing a beat? | |
| Bauer et al. | Biomarker Periodic Repolarization Dynamics Indicates Enhanced Risk for Arrhythmias and Sudden Cardiac Death in Myocardial Infarction in Pigs | |
| Musso | Articles in PresS. Am J Physiol Heart Circ Physiol (March 18, 2016). doi: 10.1152/ajpheart. 00035.2015 | |
| Lai et al. | On the mechanisms of arrhythmias in the myocardium of mXinα-deficient murine left atrial-pulmonary veins | |
| Muñoz et al. | Impaired S-nitrosylation of Cx43 prevents arrhythmogenicity and myocardial injury upon cardiac stress in Duchenne Muscular Dystrophy |